Advances in Molecular Pathology: Advances, cartea 6-1
Editat de Gregory J. Tsongalisen Limba Engleză Hardback – 20 oct 2023
| Toate formatele și edițiile | Preț | Express |
|---|---|---|
| Hardback (2) | 912.09 lei 5-7 săpt. | |
| Elsevier – 7 noi 2022 | 912.09 lei 5-7 săpt. | |
| Elsevier – 20 oct 2023 | 912.25 lei 5-7 săpt. |
Din seria Advances
- 5%
Preț: 723.82 lei - 5%
Preț: 907.19 lei - 5%
Preț: 1235.19 lei - 5%
Preț: 932.67 lei - 5%
Preț: 1233.23 lei - 5%
Preț: 1165.24 lei - 5%
Preț: 1163.86 lei - 5%
Preț: 1233.93 lei - 5%
Preț: 1275.43 lei - 5%
Preț: 1131.17 lei - 25%
Preț: 740.95 lei - 24%
Preț: 673.94 lei - 30%
Preț: 991.45 lei - 5%
Preț: 822.83 lei - 30%
Preț: 981.87 lei - 25%
Preț: 670.21 lei - 25%
Preț: 593.46 lei - 25%
Preț: 712.99 lei - 25%
Preț: 739.49 lei - 25%
Preț: 865.05 lei - 25%
Preț: 811.35 lei - 24%
Preț: 795.19 lei - 25%
Preț: 813.08 lei - 25%
Preț: 875.21 lei - 30%
Preț: 876.25 lei - 5%
Preț: 496.08 lei - 29%
Preț: 599.27 lei - 25%
Preț: 980.56 lei - 24%
Preț: 674.57 lei - 25%
Preț: 812.25 lei - 32%
Preț: 854.34 lei - 30%
Preț: 862.60 lei - 5%
Preț: 859.87 lei - 24%
Preț: 989.48 lei - 25%
Preț: 692.42 lei - 25%
Preț: 804.04 lei - 25%
Preț: 912.74 lei - 5%
Preț: 912.19 lei - 5%
Preț: 914.55 lei - 25%
Preț: 597.29 lei - 5%
Preț: 859.10 lei - 30%
Preț: 856.00 lei - 25%
Preț: 889.93 lei - 32%
Preț: 859.11 lei - 25%
Preț: 840.63 lei - 5%
Preț: 912.09 lei - 5%
Preț: 495.33 lei - 5%
Preț: 913.07 lei - 27%
Preț: 597.80 lei - 5%
Preț: 1317.29 lei
Preț: 912.25 lei
Preț vechi: 1298.69 lei
-30%
Puncte Express: 1368
Preț estimativ în valută:
161.17€ • 185.62$ • 139.52£
161.17€ • 185.62$ • 139.52£
Carte tipărită la comandă
Livrare economică 05-19 mai
Specificații
Cuprins
The Landscape of Clinical Whole Genome Sequencing and the Emergence of Rapid Genetic Diagnosis in Critical Care
Blastic Plasmacytoid Dendritic Cell Neoplasm: Advances in Molecular Markers and Treatments
Molecular Classification of Diffuse Large B Cell Lymphoma: Impact on Prognosis and Treatment
B-Lymphoblastic Leukemia/Lymphoma: Newly Defined Entities and Subtypes by Molecular Methods
Molecular Diagnostics for Invasive Fungal Infections: Barriers to Widespread Adoption and Opportunities for Improvement
Recently Updated Sexually Transmitted Infection Screening Guidelines and Impact on Molecular Diagnostics
Quantitative Viral Load Monitoring: How far are We from Commutable Results?
The Current State of Pharmacoeconomics and Reimbursement for Pharmacogenomics
Long-read Sequencing for Germline Pharmacogenomic Testing
Practical Approaches to Pharmacogenomics in Patients Using Vitamins/Supplements and Medical Marijuana
Computer-Based Simulation of DNA Short[1]Read Next-Generation Sequencing: A Review of Software from a Clinical Perspective
Minimal Residual Disease Testing in Solid Tumors,
Mutational Signatures in Solid Tumors
Multi-Cancer Early Detection: Blood-Based Screening, Multiomics, Machine Learning, and New Clinical Pathways
Rapid Whole Genome Sequencing in Critically Ill Newborns
Molecular Diagnosis of Emerging Pathogens: Policy and Practical Considerations for Laboratorians
Blastic Plasmacytoid Dendritic Cell Neoplasm: Advances in Molecular Markers and Treatments
Molecular Classification of Diffuse Large B Cell Lymphoma: Impact on Prognosis and Treatment
B-Lymphoblastic Leukemia/Lymphoma: Newly Defined Entities and Subtypes by Molecular Methods
Molecular Diagnostics for Invasive Fungal Infections: Barriers to Widespread Adoption and Opportunities for Improvement
Recently Updated Sexually Transmitted Infection Screening Guidelines and Impact on Molecular Diagnostics
Quantitative Viral Load Monitoring: How far are We from Commutable Results?
The Current State of Pharmacoeconomics and Reimbursement for Pharmacogenomics
Long-read Sequencing for Germline Pharmacogenomic Testing
Practical Approaches to Pharmacogenomics in Patients Using Vitamins/Supplements and Medical Marijuana
Computer-Based Simulation of DNA Short[1]Read Next-Generation Sequencing: A Review of Software from a Clinical Perspective
Minimal Residual Disease Testing in Solid Tumors,
Mutational Signatures in Solid Tumors
Multi-Cancer Early Detection: Blood-Based Screening, Multiomics, Machine Learning, and New Clinical Pathways
Rapid Whole Genome Sequencing in Critically Ill Newborns
Molecular Diagnosis of Emerging Pathogens: Policy and Practical Considerations for Laboratorians